You are here

Article Text

Article menu
Download PDFPDF
Commentary
Cochrane neurological network corner
Commentary on “Immunosuppressant drugs for myasthenia gravis”
  1. Maria Grazia Celani,
  2. Peter Sandercock,
  3. Graeme Hankey,
  4. Cochrane Neurological Network
  1. Dr Maria Grazia Celani, Dipartimento di medicina Servizio per le Mt Cerebrovascolari via Guerra 17, 06127 Perugia, Italy; mgcelani{at}iol.it

http://dx.doi.org/10.1136/jnnp.2008.160788

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The choice of treatments for this chronic, disabling yet rare disorder is limited and founded on a weak evidence base. The conclusion that corticosteroid treatment offers significant short-term benefit is based on sources of evidence …

    View Full Text

    Footnotes

    • Competing interests: None.

    Linked Articles

    • Cochrane neurological network corner
      Immunosuppressant drugs for myasthenia gravis
      I K Hart T Sharshar S Sathasivam
      Journal of Neurology, Neurosurgery & Psychiatry 2008; 80 5-6 Published Online First: 16 Dec 2008. doi: 10.1136/jnnp.2008.144980